From the Melbourne Sexual Health Centre, Alfred Health.
Sex Transm Dis. 2023 Oct 1;50(10):664-670. doi: 10.1097/OLQ.0000000000001847. Epub 2023 Jul 4.
Electronic health records allow for inexpensive communication with patients. In March 2021, the Melbourne Sexual Health Centre implemented an automated email summary ("Sexual Health Automated Visit Email" [SHAVE]) of a client's visit. This study evaluates the proportion of attendees at a sexual health service who opted in or out of SHAVE.
This study was conducted at the Melbourne Sexual Health Centre in Australia between March 2021 and June 2022. Univariable and multivariable logistic regression analyses were used to examine the client characteristics associated with consenting to SHAVE.
There were 18,528 clients (men, 12,700; women, 5828) included in the final analysis and 55.2% (n = 10,233) consented to receiving SHAVE. Comparing with those who did not have a new sexually transmitted infection diagnosis, clients with a new diagnosis of a sexually transmitted infection, but not HIV, had lower odds of consenting to receiving SHAVE (chlamydia: adjusted odds ratio [aOR], 0.64 [95% confidence interval {CI}, 0.57-0.72]; gonorrhea: aOR, 0.71 [95% CI, 0.62-0.82]; syphilis: aOR, 0.75 [95% CI, 0.59-0.96]). Men had lower odds of consenting when compared with women (men who have sex with women only: aOR, 0.77 [95% CI, 0.71-0.84]; men who have sex with men: aOR, 0.68 [95% CI, 0.62-0.75]). Comparing with those born in Australia or Oceania, clients born in Europe had lower odds of consenting (aOR, 0.81; 95% CI, 0.70-0.94), whereas those born in Latin America or Caribbean had higher odds of consenting (aOR, 1.25; 95% CI, 1.04-1.51).
Email summaries may serve as a valuable strategy to improve health communication and record keeping for clients. Understanding the client characteristics associated with consenting SHAVE will allow for the implementation of strategies to better communicate with clients.
电子健康记录可实现与患者的廉价沟通。2021 年 3 月,墨尔本性健康中心实施了客户就诊的自动电子邮件摘要(“性健康自动就诊电子邮件”[SHAVE])。本研究评估了参加性健康服务的患者选择加入或退出 SHAVE 的比例。
本研究于 2021 年 3 月至 2022 年 6 月在澳大利亚墨尔本性健康中心进行。使用单变量和多变量逻辑回归分析来研究与同意接受 SHAVE 相关的客户特征。
最终分析包括 18528 名客户(男性 12700 名,女性 5828 名),其中 55.2%(n=10233)同意接收 SHAVE。与没有新的性传播感染诊断的患者相比,新诊断为性传播感染但非 HIV 的患者同意接收 SHAVE 的可能性较低(衣原体:调整后的优势比[OR],0.64[95%置信区间{CI},0.57-0.72];淋病:OR,0.71[95%CI,0.62-0.82];梅毒:OR,0.75[95%CI,0.59-0.96])。与女性相比,男性同意的可能性较低(仅与女性发生性关系的男性:OR,0.77[95%CI,0.71-0.84];与男性发生性关系的男性:OR,0.68[95%CI,0.62-0.75])。与出生在澳大利亚或大洋洲的患者相比,出生在欧洲的患者同意的可能性较低(OR,0.81[95%CI,0.70-0.94]),而出生在拉丁美洲或加勒比地区的患者同意的可能性较高(OR,1.25[95%CI,1.04-1.51])。
电子邮件摘要可以作为改善客户健康沟通和记录保存的有价值策略。了解与同意 SHAVE 相关的客户特征将允许实施更好地与客户沟通的策略。